ECOWAS Essential Medicines & Vaccines
WA-MRH
Lang
English
French
Portuguese
ECOWAS Essential Medicines & Vaccines
WA-MRH
About Us
Overview - History & Mission
What We Do
Benefits
Success Stories
WA-MRH
Partners
Member Login
Communities of Practice
Member States
Benin
Burkina Faso
Cabo Verde
Cote d'Ivoire
The Gambia
Ghana
Guinea
Guinea-Bissau
Liberia
Mali
Niger
Nigeria
Senegal
Sierra Leone
Togo
ECOWAS
Regional Basket
Events & News
News media
Upcoming Events
Photo Gallery
Video Gallery
Document Center
Guidelines
SOPs
Manuals
Templates
Library
Publications
|
Lang
English
French
Portuguese
We use cookies, just to track visits to our website, we store no personal details.
Learn More
Accept
DrugLens ISSUE 8 | August 2020
Author:
Ghana FDA
Category:
Country
Language:
English
Date Updated:
Description
DrugLens, a biannual publication by the National Pharmacovigilance Centre of the Food and Drugs Authority (FDA). This newsletter gives a summary of the ADR reports received , drug safety issues of current interest, pharmacovigilance awareness activities and safety monitoring activities by the National Pharmacovigilance Centre. DrugLens is also one of the FDA's commitment to building a world class regulatory authority by communicating timely and accurate safety information and other related activities to stakeholders.
Abstract
DrugLens provides pertinent information regarding new and emerging drug safety issues in Ghana. This information will be used by health care professionals to assist in making the best decisions regarding the use of medicines and to promote the reporting of adverse drug reactions (ADRs). ADR reports received from healthcare professionals helps the FDA in taking appropriate regulatory decisions regarding marketed products ensures that patients derive the maximum benefit from pharmacotherapy.
Download PDF
Back To List
Feedback
×
Submit a feedback
Contact Email
Feedback Title
Feedback
Submit